Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.

Article English OPEN
Horvath, K; Jeitler, K; Berghold, A; Ebrahim, S H; Gratzer, T W; Plank, J; Kaiser, T; Pieber, T R; Siebenhofer, A;
  • Publisher: Cochrane Collaboration
  • Subject:
    mesheuropmc: endocrine system diseases

Despite indications from epidemiological trials that higher blood glucose concentrations are associated with a higher risk for developing micro- and macrovascular complications, evidence for a beneficial effect of antihyperglycaemic therapy in patients with type 2 diabe... View more
  • References (15)
    15 references, page 1 of 2

    Garber 2003 {published data only} Garber AJ. Benefits of combination therapy of insulin and oral hypoglycemic agents. Archives of Internal Medicine 2003;163(15):1781-2.

    Kacerovsky-Bielesz {published data only} Authors Kacerovsky-Bielesz G, Dressler A, Freunscht, R. Long-term glycaemic control with insulin glargine in Type 2 diabetes. Diabetes Research & Clinical Practice 2006;71: 184-91.

    Kaplan 2004 {published data only} Kaplan W, Rodriguez LM, Smith OE, Haymond MW, Heptulla RA. Effects of mixing glargine and short-acting insulin analogs on glucose control. Diabetes care 2004;27 (11):2739-40.

    Krankenpflege 2004 {published data only} Anonymous. Lantus is superior in BOT (basic oral therapy) to standard mixed insulin. Krankenpflege Journal 2004;42 (5-6):172.

    Nakhmanovich 2001 {published data only} Nakhmanovich Y, Belenkaya R, Rozenfeld V. Insulin glargine in the management of diabetes mellitus. Pharmacy and Therapeutics 2001;26(4):176-81.

    Riddle 2006 {published data only} Riddle MC. The Treat-to-Target Trial and related studies. Endocrine Practice 2006;12 Suppl 1:71-9.

    Stoneking 2005 {published data only} Stoneking K. Initiating basal insulin therapy in patients with type 2 diabetes mellitus. American Journal of HealthSystem Pharmacy 2005;62(5):510-8.

    Kawamori 2003 {published data only} Kawamori R, Iwamoto Y, Kadowaki T, Manabu Iwasaki. Efficacy and safety of insulin glargine in concurrent use with oral hypoglycemic agents for the treatment of Type 2 diabetes patients. Rinshoiyaku 2003;19(5):445-64.

    EMEA 2003 20. European Public Assessment Report (EPAR) on Lantus (Insulin Glargine) - Scientific Discussion (2003). http://www.emea.eu.int/humandocs/PDFs/EPAR/Lantus/ 061500en6.pdf (accessed 16 August 2006).

    EMEA 2004 18. European Public Assessment Report (EPAR) on Levemir (Insulin Detemir) - Scientific Discussion (2004). http://www.emea.eu.int/humandocs/PDFs/EPAR/levemir/ 093604en6.pdf (accessed 16 August 2006).

  • Related Organizations (1)
  • Metrics
Share - Bookmark